Indira Joshi

626 total citations
30 papers, 465 citations indexed

About

Indira Joshi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Indira Joshi has authored 30 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Indira Joshi's work include Immunotherapy and Immune Responses (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and CAR-T cell therapy research (4 papers). Indira Joshi is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and CAR-T cell therapy research (4 papers). Indira Joshi collaborates with scholars based in United States and France. Indira Joshi's co-authors include Mitchell R. Smith, Fang Jin, Debra G. B. Leonard, Lawrence G. Lum, Joseph P. Uberti, John B. Das, Arvin I. Philippart, Lyle L. Sensenbrenner, Mikio Ueda and Tao Xie and has published in prestigious journals such as Neuron, Blood and PLoS ONE.

In The Last Decade

Indira Joshi

30 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indira Joshi United States 12 209 116 93 88 62 30 465
D Oberberg Germany 12 145 0.7× 186 1.6× 159 1.7× 53 0.6× 39 0.6× 22 499
Haruki Oyaizu Japan 11 251 1.2× 76 0.7× 79 0.8× 156 1.8× 36 0.6× 14 512
Luisa Roncali Italy 9 255 1.2× 84 0.7× 25 0.3× 70 0.8× 38 0.6× 11 502
Michele Pelosi Italy 12 325 1.6× 89 0.8× 312 3.4× 135 1.5× 57 0.9× 16 717
Toshimitsu Aida Japan 15 165 0.8× 85 0.7× 58 0.6× 130 1.5× 34 0.5× 46 508
Vadim Tchaikovski Netherlands 9 279 1.3× 106 0.9× 131 1.4× 61 0.7× 28 0.5× 11 515
Irune Ruiz Spain 13 348 1.7× 164 1.4× 42 0.5× 151 1.7× 62 1.0× 25 672
Shu-Yin Ho United States 6 217 1.0× 85 0.7× 64 0.7× 19 0.2× 39 0.6× 7 376
Lihong Hou China 11 317 1.5× 96 0.8× 80 0.9× 60 0.7× 25 0.4× 29 538
Steven Song United States 6 327 1.6× 165 1.4× 79 0.8× 84 1.0× 24 0.4× 10 550

Countries citing papers authored by Indira Joshi

Since Specialization
Citations

This map shows the geographic impact of Indira Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indira Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indira Joshi more than expected).

Fields of papers citing papers by Indira Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indira Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indira Joshi. The network helps show where Indira Joshi may publish in the future.

Co-authorship network of co-authors of Indira Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Indira Joshi. A scholar is included among the top collaborators of Indira Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indira Joshi. Indira Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiss, Robert Frank, et al.. (2012). Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma. PLoS ONE. 7(12). e51736–e51736. 4 indexed citations
2.
Bradley, Sarah V., Mitchell R. Smith, Teresa S. Hyun, et al.. (2007). Aberrant Huntingtin Interacting Protein 1 in Lymphoid Malignancies. Cancer Research. 67(18). 8923–8931. 25 indexed citations
3.
Smith, Mitchell R., Fang Jin, & Indira Joshi. (2007). Bortezomib Sensitizes Non–Hodgkin's Lymphoma Cells to Apoptosis Induced by Antibodies to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) Receptors TRAIL-R1 and TRAIL-R2. Clinical Cancer Research. 13(18). 5528s–5534s. 36 indexed citations
4.
Smith, Mitchell R., Indira Joshi, Fang Jin, & Coleman K. Obasaju. (2005). Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice. BMC Cancer. 5(1). 103–103. 20 indexed citations
5.
Smith, Mitchell R., Fang Jin, & Indira Joshi. (2004). Antibodies to TRAIL Receptors R1 and R2 Induce Apoptosis in Non-Hodgkin’s Lymphoma Cells.. Blood. 104(11). 3290–3290. 1 indexed citations
6.
Smith, Mitchell R., Fang Jin, & Indira Joshi. (2004). Bortezomib Sensitizes Non-Hodgkin’s Lymphoma Cells to Apoptosis Induced by Antibodies to TRAIL Receptors R1 and R2.. Blood. 104(11). 4614–4614. 3 indexed citations
7.
Haas, Naomi B., Mitchell R. Smith, Nancy Lewis, et al.. (2003). Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.. PubMed. 9(1). 109–14. 25 indexed citations
8.
Smith, Mitchell R., et al.. (2000). Antisense oligonucleotides complementary to immunoglobulin sequences of BCL-2/immunoglobulin fusion transcript induce apoptosis of t(14;18) lymphoma cells. British Journal of Haematology. 111(4). 1087–1092. 7 indexed citations
9.
Wang, Y. Lynn, Hanna Rennert, Indira Joshi, et al.. (1999). Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence‐based carrier testing for spinal muscular atrophy. American Journal of Medical Genetics. 85(5). 463–469. 1 indexed citations
10.
Smith, Mitchell R., et al.. (1998). Dexamethasone plus retinoids decrease IL‐6/IL‐6 receptor and induce apoptosis in myeloma cells. British Journal of Haematology. 102(4). 1090–1097. 20 indexed citations
11.
Garbern, James, Franca Cambi, Anders A. F. Sima, et al.. (1997). Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin. Neuron. 19(1). 205–218. 111 indexed citations
13.
Moore, Patricia M., Indira Joshi, & Smita Ghanekar. (1994). Affinity isolation of neuron‐reactive antibodies in MRL/lpr mice. Journal of Neuroscience Research. 39(2). 140–147. 11 indexed citations
14.
Lum, Lawrence G., Indira Joshi, Mitchell R. Smith, et al.. (1994). Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.. PubMed. 13(2). 187–95. 10 indexed citations
15.
Lum, Lawrence G., Indira Joshi, Esteban Abella, et al.. (1993). Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.. PubMed. 12(6). 565–71. 3 indexed citations
16.
Ueda, Mikio, Indira Joshi, Maria Dan, et al.. (1993). Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.. PubMed. 56(2). 351–6. 26 indexed citations
17.
Das, John B., Indira Joshi, & Arvin I. Philippart. (1983). Continuous monitoring of pH in the tissue mode: Evaluation of a miniature sensor during acidosis and tissue hypoperfusion. Journal of Pediatric Surgery. 18(6). 914–921. 12 indexed citations
18.
Das, John B., Indira Joshi, & Arvin I. Philippart. (1981). Intralipid intolerance in pancreatitis: The role of hepatic triglyceride lipase in plasma clearance of the lipid emulsion. Journal of Pediatric Surgery. 16(6). 1021–1028. 6 indexed citations
19.
Das, John B., Indira Joshi, & Arvin I. Philippart. (1980). Depression of glucose utilization by intralipid in the post-traumatic period: An experimental study. Journal of Pediatric Surgery. 15(6). 739–745. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026